LC knows a Big Pharma deal is coming. What a wonderful brilliant...

LC knows a Big Pharma deal is coming.
What a wonderful brilliant smiling poker face she had in that video. Holding 5 aces and smiling ear to ear. She's the one in the negotiating seat and driving the talks.

Shareholders will receive a decent proportion, usually in vicinity of 70_80%, of any upfront payment and subsequent milestone payments.

Option holders will not.

Look at the recent size of immuno oncology deals. Look at the size of the first CAR T deals.
US$Billion deals . US$150 -200 Million in the upfront payment for a cautious deal.

Could be double that if the data is compelling and a Big Pharma wants to lock in the B Cell platform with exclusivity.

3-5c distribution to share holders in a base case. Zero payment to option holders.

Do the maths, LC will then be able to convert the remainder of her options for about $1.3 million received with a distribution of 4c per share paid to her 30 million shares currently held. (80% payout on a US$165million upfront partnership)

Preparing for tax loss selling in June thinking buying back cheaper completely back fired. Preparing for a market sell off that may or may not happen could just as easily backfire. Buying undervalued stocks in any market rarely backfires.

Preparing for something that you have a lot of control over and confidence will happen, in LC's case, is not hard.

We've been given so many clues its not funny.

Two new IND trials designed for "a slew of early data" , and a HerVax interim data readout extended for 6 -9 months because patients PFS has been longer than expected.
Good luck trying to out smart the market! "Money will always follow the science", and our CEO has just proven that and opened the way for more to follow.